The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches
-
* Corresponding author: Stephan Harbarth harbarth@post.harvard.edu
BMC Infectious Diseases 2001, 1:5 doi:10.1186/1471-2334-1-5
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 26 Apr 2001 | |
| Resubmission - Version 2 | Manuscript | 27 Apr 2001 | |
| Reviewer's Report | Dorothy Rice | 13 Jun 2001 | |
| Reviewer's Report | Ken Smith | 13 Jun 2001 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 18 Jun 2001 |
| Resubmission - Version 4 | Manuscript | Author's comment | 19 Jun 2001 |
| Resubmission - Version 5 | 28 Jun 2001 | ||
| Resubmission - Version 6 | Manuscript | Author's comment | 28 Jun 2001 |
| Published | 28 Jun 2001 | ||
| Resubmission - Version 7 | Manuscript | 28 Jun 2001 | |
| Published | 28 Jun 2001 |